Sanofi's Genzyme sues Allergan over royalties on Juvederm dermal fillers
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis's Genzyme unit has sued Allergan in a dispute over royalties related to Allergan's line of Juvederm (cross-linked hyaluronic acid) dermal fillers. The injections are used to fill in wrinkles around the nose and mouth.